• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自乳化制剂提高了维生素E的生物利用度。

Improved bioavailability of vitamin E with a self emulsifying formulation.

作者信息

Julianto T, Yuen K H, Noor A M

机构信息

Department of Pharmaceutics, School of Pharmaceutical Sciences, University of Science Malaysia, Penang.

出版信息

Int J Pharm. 2000 Apr 25;200(1):53-7. doi: 10.1016/s0378-5173(00)00337-9.

DOI:10.1016/s0378-5173(00)00337-9
PMID:10845685
Abstract

A single dose study was conducted to evaluate the bioavailability of a novel self-emulsifying vitamin E preparation, in comparison with that of a commercial product, Natopherol, available as soft gelatin capsules under fasted condition. The self-emulsifying preparation achieved a faster rate and higher extent of absorption. A statistically significant difference was observed between the values of the two preparations in the parameters AUC, Cmax and Tmax. Moreover, the 90% confidence interval of the logarithmic transformed AUC values of the self-emulsifying preparation over those of the soft gelatin capsule product was found to be between 2.1 and 4.1, suggesting an increase in bioavailability of between 210 and 410%. As for Cmax, the 90% confidence interval was between 2.1 and 3.0. However, no statistically significant difference was observed between the t(1/2) values estimated from the plasma concentration versus time data of the two preparations. The values are also comparable to those reported in the literature.

摘要

开展了一项单剂量研究,以评估一种新型自乳化维生素E制剂与市售产品Natopherol(以软胶囊形式提供)在禁食条件下的生物利用度。自乳化制剂实现了更快的吸收速率和更高的吸收程度。在AUC、Cmax和Tmax参数方面,观察到两种制剂的值存在统计学显著差异。此外,发现自乳化制剂与软胶囊产品的对数转换AUC值的90%置信区间在2.1至4.1之间,表明生物利用度提高了210%至410%。至于Cmax,90%置信区间在2.1至3.0之间。然而,根据两种制剂的血浆浓度与时间数据估计的t(1/2)值之间未观察到统计学显著差异。这些值也与文献报道的值相当。

相似文献

1
Improved bioavailability of vitamin E with a self emulsifying formulation.自乳化制剂提高了维生素E的生物利用度。
Int J Pharm. 2000 Apr 25;200(1):53-7. doi: 10.1016/s0378-5173(00)00337-9.
2
Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations.脂解作用和液滴大小对自乳化制剂中生育三烯酚吸收的影响。
Int J Pharm. 2004 Aug 20;281(1-2):67-78. doi: 10.1016/j.ijpharm.2004.05.015.
3
Polysaccharide formulation for improvement of racemic vitamin E bioavailability.用于提高外消旋维生素E生物利用度的多糖制剂。
Acta Pol Pharm. 2007 Mar-Apr;64(2):169-74.
4
Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.含新型自纳米乳化制剂的软胶囊中,无论是否进食,环孢素A的生物利用度均稳定。
Int J Clin Pharmacol Ther. 2006 May;44(5):233-9. doi: 10.5414/cpp44233.
5
Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status.不同饮食状态下α-、γ-和δ-生育三烯酚的药代动力学和生物利用度
J Pharm Pharmacol. 2001 Jan;53(1):67-71. doi: 10.1211/0022357011775208.
6
Bioavailability and pharmacokinetics of acyclovir tablet preparation.阿昔洛韦片剂制剂的生物利用度和药代动力学
Drug Dev Ind Pharm. 1998 Feb;24(2):193-6. doi: 10.3109/03639049809085607.
7
Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.草药产品中活性成分在人体中的口服生物利用度。一项使用软胶囊技术对贯叶连翘提取物的研究。
Phytomedicine. 2000 Dec;7(6):455-62. doi: 10.1016/S0944-7113(00)80029-X.
8
Absorption of vitamin K2 by dogs after oral administration of a soft gelatin capsule formulation containing a new emulsion-type vehicle.口服含有新型乳剂型载体的软胶囊制剂后犬对维生素K2的吸收情况。
J Pharm Pharmacol. 1999 Dec;51(12):1375-80. doi: 10.1211/0022357991777191.
9
The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.非诺贝特自微乳化制剂的体外和体内评价
Curr Drug Deliv. 2015;12(3):308-13.
10
Comparative bioavailability study of doxycycline hyclate (equivalent to 100 mg doxycycline) capsules (doxycin vs vibramycin) for bioequivalence evaluation in healthy adult volunteers.盐酸多西环素(相当于100毫克多西环素)胶囊(强力霉素与威霸霉素)在健康成年志愿者中进行生物等效性评价的比较生物利用度研究。
Int J Clin Pharmacol Ther. 2004 Jul;42(7):373-7. doi: 10.5414/cpp42373.

引用本文的文献

1
Pharmacokinetics of vitamin dosage forms: A complete overview.维生素剂型的药代动力学:全面概述。
Food Sci Nutr. 2023 Nov 9;12(1):48-83. doi: 10.1002/fsn3.3787. eCollection 2024 Jan.
2
Vitamin E beyond Its Antioxidant Label.超越抗氧化标签的维生素E
Antioxidants (Basel). 2021 Apr 21;10(5):634. doi: 10.3390/antiox10050634.
3
Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery.自纳米乳化药物递送系统:从开发到口服药物递送的当前应用与挑战
Pharmaceutics. 2020 Dec 9;12(12):1194. doi: 10.3390/pharmaceutics12121194.
4
Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.脂质纳米载体在改善维生素口服递送中的应用。
Nutrients. 2019 Jan 1;11(1):68. doi: 10.3390/nu11010068.
5
Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems.将脂肪分解纳入脂质体口服给药系统单层渗透研究中。
Drug Deliv Transl Res. 2018 Apr;8(2):375-386. doi: 10.1007/s13346-017-0383-6.
6
Validation of a HPLC/FLD Method for Quantification of Tocotrienols in Human Plasma.用于定量测定人血浆中生育三烯酚的高效液相色谱/荧光检测法的验证
Int J Anal Chem. 2015;2015:357609. doi: 10.1155/2015/357609. Epub 2015 Oct 28.
7
Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.基于脂质的制剂的药代动力学方面及体外-体内相关性潜力。
Acta Pharm Sin B. 2014 Oct;4(5):333-49. doi: 10.1016/j.apsb.2014.09.001. Epub 2014 Oct 8.
8
Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration.乳化 γ-生育三烯酚的组织分布及其皮下给药后的长期生物学效应。
Lipids Health Dis. 2014 Apr 9;13:66. doi: 10.1186/1476-511X-13-66.
9
Bioavailability of tocotrienols: evidence in human studies.生育三烯酚的生物利用度:人体研究证据。
Nutr Metab (Lond). 2014 Jan 13;11(1):5. doi: 10.1186/1743-7075-11-5.
10
Clinical studies with oral lipid based formulations of poorly soluble compounds.口服脂基制剂改善难溶性化合物的临床研究。
Ther Clin Risk Manag. 2007 Aug;3(4):591-604.